Jena University Hospital
Clinical trials sponsored by Jena University Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug targets Antibody-Producing cells in brain inflammation Results expected Sep 2026 (estimated)
- Could bile acid fingerprints prevent stillbirths in pregnancy cholestasis? Results expected Dec 2026 (estimated)
-
Can a new chemo schedule tame side effects in prostate cancer?
Disease control OngoingThis phase 3 trial is testing whether giving the chemotherapy drug docetaxel more often but at a lower dose—every 2 weeks instead of every 3 weeks—can reduce severe side effects in men with metastatic hormone-sensitive prostate cancer. All participants also receive the standard c…
Phase 3 • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New balloon could save legs from amputation in PAD patients
Disease control OngoingThis study compares a special balloon coated with sirolimus (a drug that prevents re-blockage) to a standard balloon for opening blocked arteries below the knee in people with peripheral artery disease. About 230 participants will be randomly assigned to one of the two treatments…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New balloon treatment for blocked leg arteries put to the test
Disease control OngoingThis study compares two types of drug-coated balloons used to open blocked arteries in the leg. About 478 people with peripheral artery disease will receive either a sirolimus-coated balloon or a paclitaxel-coated balloon. The goal is to see if the sirolimus balloon works as well…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New study aims to predict who can skip surgery for rectal cancer
Knowledge-focused OngoingThis pilot study is testing whether regular MRI scans and blood tests can accurately track how rectal cancer responds to pre-surgery treatment. The goal is to develop a way to predict complete remission without needing surgery. Forty adults with locally advanced rectal cancer wil…
Sponsor: Jena University Hospital • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC